SPRYCEL(R) (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec(R)* in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase